Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preterm Birth in Women With HIV: The Role of the Placenta. | Front Glob Womens Health | 2022 | 35392117 | PubTator, text mining | PubMed |
| Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer. | Front Immunol | 2022 | 35392092 | PubTator, text mining | PubMed |
| Variation in the co-expression profile highlights a loss of miRNA-mRNA regulation in multiple cancer types. | Noncoding RNA Res | 2022 | 35387279 | PubTator, text mining | PubMed |
| Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome. | Front Med (Lausanne) | 2022 | 35372412 | PubTator, text mining | PubMed |
| Lipid Droplet-Related PLIN2 in CD68+ Tumor-Associated Macrophage of Oral Squamous Cell Carcinoma: Implications for Cancer Prognosis and Immunotherapy. | Front Oncol | 2022 | 35372038 | PubTator, text mining | PubMed |
| APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma. | J Cancer | 2022 | 35371313 | PubTator, text mining | PubMed |
| Zika Virus Neuropathogenesis: The Different Brain Cells, Host Factors and Mechanisms Involved. | Front Immunol | 2022 | 35371036 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates. | Int J Gen Med | 2022 | 35368798 | PubTator, text mining | PubMed |
| Interferon regulatory factor 5‑induced upregulation of zinc‑finger protein 217 promotes pancreatic carcinoma progression. | Mol Med Rep | 2022 | 35362545 | PubTator, text mining | PubMed |
| RAGE is a potential biomarker implicated in immune infiltrates and cellular senescence in lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35358337 | PubTator, text mining | PubMed |
| ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation. | Front Pharmacol | 2022 | 35355726 | PubTator, text mining | PubMed |
| Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells. | Pharmaceuticals (Basel) | 2022 | 35337104 | PubTator, text mining | PubMed |
| The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid. | Viruses | 2022 | 35336928 | PubTator, text mining | PubMed |
| Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex Workers. | Viruses | 2022 | 35336878 | PubTator, text mining | PubMed |
| A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects. | Molecules | 2022 | 35335337 | PubTator, text mining | PubMed |
| Transposable Elements: Major Players in Shaping Genomic and Evolutionary Patterns. | Cells | 2022 | 35326499 | PubTator, text mining | PubMed |
| A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis. | Korean J Fam Med | 2022 | 35320902 | PubTator, text mining | PubMed |
| Immunocolocalization of Interferon Regulatory Factory 5 with Tumor Necrosis Factor Receptor-associated Factor 6 and AKT2 in Human Apical Periodontitis. | J Endod | 2022 | 35314291 | PubTator, text mining | PubMed |
| Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. | BMC Cancer | 2022 | 35313846 | PubTator, text mining | PubMed |
| Roles of Plasmacytoid Dendritic Cells in Gastric Cancer. | Front Oncol | 2022 | 35311157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=57